2022 AACR Meeting
Wayshine Biopharm attended AACR 2022 in New Orleans, and associated with Mayo Clinic to present the poster with impressive preclini Release time:2022-04-18
2020-0115 JPM Biotech ShowCase
JPM Biotech ShowCase, CEO/Founder Dr. Zhong presented our first-in-class small molecular brain penetrable drugs indication around GBM. An Release time:2020-01-16
2019(FIFTH)Oversea returnees starups competition
Our innovative drug for GBM with the ability to penetrate the blood-brain barrier have won an award in the Oversea Returnees (Fifth) Star Release time:2019-09-25